IBM’s 25% Plunge Unleashes a Wave of Class Actions and Dividend Doubts Ahead of July 22 Earnings
Published on 07/20/2026 at 03:11 | Redaktion boerse-global.de
The sell-off that erased more than a quarter of IBM’s market value in a single session has set off a cascade of legal investigations, a flurry of analyst downgrades, and fresh questions about the safety of a dividend that has long been a cornerstone of the stock’s appeal. At the center of the storm is a brutally candid letter from CEO Arvind Krishna, who told shareholders last week that the company had failed to anticipate how customers would reallocate spending in the AI-driven infrastructure race.
The July 14 collapse — a one-day loss of roughly 25 percent — stands as the sharpest intraday decline in Big Blue’s 115-year history, eclipsing even the 23 percent rout on Black Monday in 1987. By the end of the week, the stock had shed around 30 percent from its pre-warning level. The trigger was a preliminary second-quarter update that fell well short of Wall Street’s estimates: revenue of $17.2 billion versus a consensus of $17.86 billion, and adjusted earnings per share of $2.93 against the expected $3.01. The Infrastructure unit, which had grown 15 percent in the prior quarter, shrank by 7 percent, while software growth slowed from 11 percent to just 5 percent.
Krishna explained that many customers had rushed to lock in scarce server, storage and memory hardware ahead of expected price increases tied to AI demand, pulling forward spending that would otherwise have flowed to IBM’s own software and transaction-processing platforms. “What unfolded was worse than our expectations — driven by a drop in our Z performance and the related software stack, particularly in transaction processing,” he wrote. That admission has become the focal point for at least seven law firms — including BFA, Ademi LLP, Frank R. Cruz and Pomerantz LLP — that have opened investigations or filed shareholder warnings. They are probing whether IBM should have disclosed the shift in customer behavior sooner, and whether executives misled investors about the pace of new business wins and the outlook for the mainframe-related Z division.
Should investors sell immediately? Or is it worth buying IBM?
Analysts have responded with a fresh wave of price-target cuts. JPMorgan slashed its target from $291 to $250, Citi from $375 to $255, and Bank of America’s Wamsi Mohan lowered his from $330 to $280 while maintaining a buy rating. HSBC took the most bearish stance, downgrading the stock to “Reduce.” Oppenheimer dropped its rating from “Outperform” to “Perform,” citing a lack of progress toward IBM’s medium-term financial goals and doubts that the company can still deliver its full-year guidance or double-digit software growth. Despite the carnage, 16 of the 25 analysts covering the stock still rate it a buy, with a consensus price target around $292.89 — a level that now implies roughly 58 percent upside from Friday’s close.
The dividend, a key draw for income-focused investors, has taken on a new complexion. IBM’s quarterly payout of $1.69 per share, recently raised, now yields about 3.1 percent after the stock’s slide, up from 2.2 percent. While the company’s free cash flow of $13 billion comfortably covers the roughly $6 billion annual dividend bill, the stock’s heavy weighting in popular dividend ETFs — 8.5 percent of the First Trust Nasdaq Technology Dividend ETF, 6 percent of the Invesco Dow Jones Industrial Average Dividend Fund, and 5 percent of the iShares Core Dividend ETF — has prompted warnings from several financial publications urging retirees and individual investors not to let their single-stock exposure exceed 5 to 10 percent of a portfolio.
Institutional activity in the first quarter paints a divided picture. The Swiss National Bank increased its stake by 7.5 percent to 2.74 million shares, valued at roughly $665 million. Jennison Associates added 13 percent, lifting its position to 636,258 shares. Dorsey Wright & Associates, by contrast, slashed its holding by 78.9 percent to just 3,791 shares. The options market also reflected heightened anxiety: on the day of the crash, about 104,000 contracts changed hands, far above the normal daily volume.
The stock closed Friday at €185.72 in Europe, down 3.07 percent on the day and just over 4 percent above its 52-week low of €178.52 set on July 16. The 14-day relative strength index sits at 31.2, deep in oversold territory. All eyes are now on the full quarterly report, due Wednesday, July 22, and the 5 p.m. Eastern conference call that follows. If Krishna can convince investors that the spending shift was a one-time event tied to supply constraints, the stock could find a floor. If the numbers disappoint again, or if the legal pressure continues to mount, the selling may be far from over.
Ad
IBM Stock: New Analysis - 20 July
Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
